Have you changed your steroid pre-medication regimens when treating with chemo-immunotherapy combinations for metastatic NSCLC vs chemotherapy alone?

I have not changed the recommended premedications for chemotherapy when giving chemotherapy combined with checkpoint inhibitors as the trials did not do this. Also there does not seem to be a difference between nab-paclitaxel and taxol in trials in squamous cancers.